New Zealand markets closed

Endonovo Therapeutics, Inc. (ENDV)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0026+0.0002 (+9.58%)
At close: 10:45AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
140.242
140.242
135.355
73.105
165.796
Cost of revenue
7.84
7.84
9.99
14.985
65.369
Gross profit
132.402
132.402
125.365
58.12
100.427
Operating expenses
Total operating expenses
3,052
3,052
3,390
2,285
3,013
Operating income or loss
-2,919
-2,919
-3,264
-2,227
-2,912
Interest expense
1,282
1,282
1,322
941.566
2,083
Total other income/expenses net
11,126
11,126
-13,889
63.219
4,600
Income before tax
6,925
6,925
-18,475
-3,105
-395.584
Income tax expense
0
0
0
0
0
Income from continuing operations
6,925
6,925
-18,475
-3,105
-395.584
Net income
6,925
6,925
-18,475
-3,105
-395.584
Net income available to common shareholders
6,925
6,925
-18,475
-3,105
-395.584
Basic EPS
-0.05
-
-0.13
-0.05
-0.03
Diluted EPS
-0.07
-
-0.13
-0.05
-0.03
Basic average shares
254,570
-
139,207
59,837
12,216
Diluted average shares
1,060,380
-
139,207
59,837
12,216